Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a TaxaneLinda T. Vahdat, Joanne L. Blum, Carol J. Fabian et al.|Journal of Clinical Oncology|2009Cited by 245
Phase I Trial of the Cyclin-Dependent Kinase Inhibitor Flavopiridol in Combination with Docetaxel in Patients with Metastatic Breast CancerAntoinette R. Tan, Sandra M. Swain|Clinical Cancer Research|2004Cited by 68